Literature DB >> 17534445

Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice.

Ying Yan1, Julie Cook, Jay McQuillan, Guifang Zhang, Cory J Hitzman, Yian Wang, Timothy S Wiedmann, Ming You.   

Abstract

Effective chemoprevention of lung cancer in high-risk patients through the administration of pharmacologic or nutritional agents is urgently needed. Aerosol inhalation can deliver chemopreventive agents directly to the respiratory tract to inhibit the tumorigenic process. In this study, polyphenon E (PolyE) and (-)-epigallocatechin-3-gallate (EGCG) were administered by aerosol delivery to A/J mice beginning 2 weeks after carcinogen treatment and continuing daily by inhalation throughout the remainder of the study (20 weeks). PolyE decreased tumor load by approximately 59%. However, EGCG, both at the same dose and at a higher dose, failed to inhibit lung carcinogenesis. These results indicate that aerosol delivery of PolyE, but not EGCG, may be a useful chemopreventive protocol in subjects at high risk for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534445      PMCID: PMC1877981          DOI: 10.1593/neo.07160

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  27 in total

1.  Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.

Authors:  L W Wattenberg; T S Wiedmann; R D Estensen; C L Zimmerman; A R Galbraith; V E Steele; G J Kelloff
Journal:  Carcinogenesis       Date:  2000-02       Impact factor: 4.944

2.  (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.

Authors:  Masahito Shimizu; Atsuko Deguchi; Jin T E Lim; Hisataka Moriwaki; Levy Kopelovich; I Bernard Weinstein
Journal:  Clin Cancer Res       Date:  2005-04-01       Impact factor: 12.531

3.  Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea.

Authors:  Z Y Wang; J Y Hong; M T Huang; K R Reuhl; A H Conney; C S Yang
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

4.  Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies.

Authors:  Claire F Verschraegen; Brian E Gilbert; Evelyne Loyer; Armando Huaringa; Garrett Walsh; Robert A Newman; Vernon Knight
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

5.  Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice.

Authors:  R D Estensen; M M Jordan; T S Wiedmann; A R Galbraith; V E Steele; L W Wattenberg
Journal:  Carcinogenesis       Date:  2003-10-24       Impact factor: 4.944

6.  Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea.

Authors:  Jie Liao; Guang-Yu Yang; Eon Sub Park; Xiaofeng Meng; Yuhai Sun; Dongxuan Jia; Darren N Seril; Chung S Yang
Journal:  Nutr Cancer       Date:  2004       Impact factor: 2.900

Review 7.  Camptothecins and lung cancer: improved delivery systems by aerosol.

Authors:  N V Koshkina; J C Waldrep; V Knight
Journal:  Curr Cancer Drug Targets       Date:  2003-08       Impact factor: 3.428

8.  Inhibitory effect of green tea on the growth of established skin papillomas in mice.

Authors:  Z Y Wang; M T Huang; C T Ho; R Chang; W Ma; T Ferraro; K R Reuhl; C S Yang; A H Conney
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

9.  Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models.

Authors:  Zhongqiu Zhang; Yian Wang; Ruisheng Yao; Jie Li; Ying Yan; Marie La Regina; William L Lemon; Clinton J Grubbs; Ronald A Lubet; Ming You
Journal:  Oncogene       Date:  2004-05-06       Impact factor: 9.867

10.  Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical.

Authors:  T Tatsumura; S Koyama; M Tsujimoto; M Kitagawa; S Kagamimori
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

View more
  16 in total

1.  Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.

Authors:  Qi Zhang; Jing Pan; Ronald A Lubet; Steven M Komas; Balaraman Kalyanaraman; Yian Wang; Ming You
Journal:  Cancer Prev Res (Phila)       Date:  2015-02-02

2.  Effect of dietary Polyphenon E and EGCG on lung tumorigenesis in A/J Mice.

Authors:  Qi Zhang; Huijing Fu; Jing Pan; Jun He; Seto Ryota; Yukihiko Hara; Yian Wang; Ronald A Lubet; Ming You
Journal:  Pharm Res       Date:  2010-01-29       Impact factor: 4.200

Review 3.  Green tea and prevention of esophageal and lung cancers.

Authors:  Jian-Min Yuan
Journal:  Mol Nutr Food Res       Date:  2011-04-29       Impact factor: 5.914

4.  Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice.

Authors:  Donna E Seabloom; Arthur R Galbraith; Anna M Haynes; Jennifer D Antonides; Beverly R Wuertz; Wendy A Miller; Kimberly A Miller; Vernon E Steele; Chen S Suen; M Gerard O'Sullivan; Frank G Ondrey
Journal:  Cancer Prev Res (Phila)       Date:  2016-12-19

5.  Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia.

Authors:  Tait D Shanafelt; Timothy G Call; Clive S Zent; Jose F Leis; Betsy LaPlant; Deborah A Bowen; Michelle Roos; Kristina Laumann; Asish K Ghosh; Connie Lesnick; Mao-Jung Lee; Chung S Yang; Diane F Jelinek; Charles Erlichman; Neil E Kay
Journal:  Cancer       Date:  2012-07-03       Impact factor: 6.860

6.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 7.  Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A review.

Authors:  Xiang-Lin Tan; Simon D Spivack
Journal:  Lung Cancer       Date:  2009-01-31       Impact factor: 5.705

8.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

9.  Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

Authors:  Anne S Tsao; Diane Liu; Jack Martin; Xi-ming Tang; J Jack Lee; Adel K El-Naggar; Ignacio Wistuba; Kirk S Culotta; Li Mao; Ann Gillenwater; Yuko M Sagesaka; Waun K Hong; Vassiliki Papadimitrakopoulou
Journal:  Cancer Prev Res (Phila)       Date:  2009-11

Review 10.  Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.

Authors:  Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2009-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.